Hui Lin, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

Virginia Commonwealth University School Of Medicine (Previously MCV) - Richmond VA
Rank: Assistant Professor
Years: 2014-present

None Reported

Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis.
Cancer Res.
15;69(22):8579-84.
Date: 11 2009
www.ncbi.nlm.nih.gov/pubmed/19887608

The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair.
Mol Cancer Ther.
12(6):878-89.
Date: 06 2013
ncbi.nlm.nih.gov/pubmed/23536721

Targeting SQSTM1/p62 induces cargo loading failure and converts autophagy to apoptosis via NBK/Bik
Mol Cell Biol
34(18):3435-49
Date: 09 2014
mcb.asm.org/content/34/18/3435.long

A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis
Blood
124(17):2687-97
Date: 10 2014
www.bloodjournal.org/content/124/17/2687.long

A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations
Leukemia
29(4):807-18
Date: 04 2015
www.nature.com/doifinder/10.1038/leu.2014.296

The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR.
Blood
127(18):2219-30
Date: 05 2016
www.bloodjournal.org/content/127/18/2219.long?sso-checked=true